Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
13 pending office actions • 11 art units • 12 examiners • 0 of 13 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
National University Corporation Tokyo Medical And Dental University has 15 pending office actions in Biotechnology & Pharmaceuticals. The matters are spread among 14 distinct examiners and 13 distinct art units, indicating a diversified prosecution docket with little examiner concentration.
HUDSON, AMY ROSE is the busiest examiner, with 2 pending matters. Most active matters therefore appear to require individualized responses rather than a unified approach directed to one examiner. Counsel should preserve technical consistency across the portfolio while tailoring amendment and interview strategies to each assigned examination group.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (15%) |
| §103 only | 4 (31%) |
| §102 only | 1 (8%) |
| §112 only | 1 (8%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 3 (23%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUDSON, AMY ROSE | 2 | 74.8% | +11.7% |
| CARREIRO, CAITLIN ANN | 1 | 46.1% | +38.4% |
| COOPER, JONATHAN EPHRAIM | 1 | 46.4% | +31.8% |
| GLOVER, NELSON ALEXANDER | 1 | 41.2% | +49.8% |
| BECCIA, CHRISTOPHER J | 1 | 83.5% | +14.0% |
| TICHY, JENNIFER M.H. | 1 | 64.6% | +34.4% |
| MAI, HAO D | 1 | 49.2% | +39.4% |
| SAPKOTA, SURAJ | 1 | 0.0% | +0.0% |
| XU, XIAOYUN | 1 | 59.9% | +31.6% |
| HWANG, JINSU | 1 | 81.1% | -3.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18780198 | GUIDE DEVICE | BECCIA, CHRISTOPHER J | 62d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19108416 | ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA | CARREIRO, CAITLIN ANN | 3d overdue |
| 18892763 | POSTURE EVALUATION APPARATUS, POSTURE EVALUATION SYSTEM, POSTURE EVALUATION METHOD, AND COMPUTER READABLE MEDIUM | GLOVER, NELSON ALEXANDER | — |
| 18558824 | DENTAL ABUTMENT CONSTRUCTION MEMBER AND PRODUCTION METHOD | MAI, HAO D | — |
| 18690457 | HETERONUCLEIC ACID INCLUDING 2'-MODIFIED NUCLEOSIDE | SAPKOTA, SURAJ | — |
| 18463631 | PRODUCTION METHOD FOR THERAPEUTIC AGENT FOR ARTHROSIS, AND THERAPEUTIC AGENT FOR ARTHROSIS | HWANG, JINSU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17602035 | Pharmaceutical Composition for Treating Muscle Disease | HUDSON, AMY ROSE | 79d overdue |
| 17906444 | HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID | HUDSON, AMY ROSE | 43d overdue |
| 19108416 | ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA | CARREIRO, CAITLIN ANN | 3d overdue |
| 18780198 | GUIDE DEVICE | BECCIA, CHRISTOPHER J | 62d |
| 18905696 | DETECTION DEVICE | COOPER, JONATHAN EPHRAIM | — |
| 18892763 | POSTURE EVALUATION APPARATUS, POSTURE EVALUATION SYSTEM, POSTURE EVALUATION METHOD, AND COMPUTER READABLE MEDIUM | GLOVER, NELSON ALEXANDER | — |
| 18711318 | CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS, CELL SHEET, AND METHOD FOR PRODUCING A CELL SHEET | TICHY, JENNIFER M.H. | — |
| 18558824 | DENTAL ABUTMENT CONSTRUCTION MEMBER AND PRODUCTION METHOD | MAI, HAO D | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1636 | 2 |
| 3786 | 1 |
| 3775 | 1 |
| 1653 | 1 |
| 3772 | 1 |
| 1635 | 1 |
| 1797 | 1 |
| 1638 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19108416 | ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA | CARREIRO, CAITLIN ANN | 3786 | §103§112 | Final Rejection | 3d overdue | Pending | Mar 03, 2025 |
| 18905696 | DETECTION DEVICE | COOPER, JONATHAN EPHRAIM | 3791 | §103Other | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18892763 | POSTURE EVALUATION APPARATUS, POSTURE EVALUATION SYSTEM, POSTURE EVALUATION METHOD, AND COMPUTER READABLE MEDIUM | GLOVER, NELSON ALEXANDER | 3791 | §101§102§103 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18780198 | GUIDE DEVICE | BECCIA, CHRISTOPHER J | 3775 | §103 | Final Rejection | 62d | Pending | Jul 22, 2024 |
| 18711318 | CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS, CELL SHEET, AND METHOD FOR PRODUCING A CELL SHEET | TICHY, JENNIFER M.H. | 1653 | §102 | Non-Final OA | — | Pending | May 17, 2024 |
| 18558824 | DENTAL ABUTMENT CONSTRUCTION MEMBER AND PRODUCTION METHOD | MAI, HAO D | 3772 | §103§112 | Non-Final OA | — | Pending | May 10, 2024 |
| 18690457 | HETERONUCLEIC ACID INCLUDING 2'-MODIFIED NUCLEOSIDE | SAPKOTA, SURAJ | 1635 | §102§103§112 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18566478 | NOVEL METHOD FOR MEASURING CHOLESTEROL EFFLUX CAPACITY | XU, XIAOYUN | 1797 | §103 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18463631 | PRODUCTION METHOD FOR THERAPEUTIC AGENT FOR ARTHROSIS, AND THERAPEUTIC AGENT FOR ARTHROSIS | HWANG, JINSU | 1638 | §101§102 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18145922 | PRODUCTION METHOD FOR SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS AND PRODUCTION METHOD FOR CELL PREPARATION FOR JOINT MEDICAL TREATMENT | SCHUBERG, LAURA J | 1631 | §103 | Non-Final OA | — | Pending | Dec 23, 2022 |
| 17906444 | HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID | HUDSON, AMY ROSE | 1636 | §103§112DP | Final Rejection | 43d overdue | Pending | Sep 15, 2022 |
| 17631934 | AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT | D' AMBROSIO, THEA | 1654 | §112 | Final Rejection | 5d overdue | Pending | Jun 07, 2022 |
| 17602035 | Pharmaceutical Composition for Treating Muscle Disease | HUDSON, AMY ROSE | 1636 | §103§112DP | Non-Final OA | 79d overdue | Pending | Oct 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational University Corporation Tokyo Medical And Dental University has 13 pending office actions as of October 2026, spread across 11 art units and 12 examiners.
Amy Rose Hudson has the most, with 2 of National University Corporation Tokyo Medical And Dental University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
